High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings

Subjects

Subjects :

Highly active antiretroviral therapy -- Patient outcomes
Gene mutations -- Reports
Drug resistance in microorganisms -- Genetic aspects
Drug resistance in microorganisms -- Research
Reverse transcriptase -- Genetic aspects
Reverse transcriptase -- Research
HIV infection -- Care and treatment
HIV infection -- Genetic aspects
HIV infection -- Patient outcomes
HIV infection -- Research
Health
Health care industry

Details

Language :

English

ISSN :

10584838

Volume :

49

Issue :

2

Database :

Gale General OneFile

Journal :

Clinical Infectious Diseases

Publication Type :

Academic Journal

Accession number :

edsgcl.204465831